⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
INSM News
Insmed, Inc.
The Galien Foundation Announces 2026 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Product," and "Best Product for Rare/Orphan Diseases"
prnewswire.com
ALNY
ARQT
IONS
JAZZ
JNJ
MRK
PFE
AKBA
ARDX
BMY
BIIB
GILD
INSM
NVS
AGIO
BBIO
CRNX
GERN
KAVL
Form 8-K
sec.gov
INSM
Insmed Reports Second-Quarter 2026 Financial Results and Provides Business Update
prnewswire.com
INSM
Form 8-K
sec.gov
INSM
Insmed Announces Positive 12-Month Data from the Ongoing Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Patients with Pulmonary Arterial Hypertension
prnewswire.com
INSM
In Silico Clinical Trials Market Size to Reach USD 8.51 Billion by 2035, Growing at a 7.75% CAGR | Industry Report & Forecast 2026–2035
globenewswire.com
CERT
INSM
Palvella Therapeutics Appoints Accomplished Rare Disease Biotech Executive and Commercial Leader Matt Pauls, J.D., M.B.A., to Board of Directors
globenewswire.com
SVRA
SLNO
INSM
PVLA
PTHS
Insmed Appoints Samuele Butera as Senior Vice President, General Manager, Global Respiratory
prnewswire.com
INSM
Nasdaq-100 Index® June 2026 Quarterly Changes
globenewswire.com
NDAQ
ALAB
CRWV
NBIS
RKLB
TER
CHTR
CTSH
INSM
VRSK
ZS
Forbion Expands Global Investment Leadership with Senior Promotions and Appointment of Operating Partner
globenewswire.com
SNY
REGN
BIIB
INSM